Both the National Institute of Health and Clinical Excellence (NICE) and the British Hypertension Society (BHS) have confirmed that they are to review their blood pressure guidelines following the publication of the ASCOT Study.
In a press release, available on both sites, the two organisations confirm that following a preliminary panel they will work together to provide doctors with clear guidance as soon as possible.
There is no indication at this stage what alterations might be made to the existing guidelines. Furthermore, there is no interim advice from either organisation.
Action: Clinicians are encouraged to await clearer guidance from NICE and BHS. Until this guidance is forthcoming continue to follow NICE (or BHS) recommendations.
|« Patient Reporting of ADRs||Ethosuximide capsules discontinued »|